WeVote
Log In

Bill

Bill

SB 680

Individualized Investigational Treatments for Life-threatening or Severely Debilitating Illnesses

2025 Regular Session Introduced by Ana Maria Rodriguez

Florida bill allowing terminally ill patients to access unapproved drugs and devices outside FDA oversight died in committee after indefinite postponement.

Died in Health Policy
#subjectindex
0
WeVote Research Nonpartisan
Bill Summary · SB 680

Legislative bill overview

SB 680 would have expanded access to investigational treatments for patients with life-threatening or severely debilitating illnesses by allowing them to use unapproved drugs and medical devices outside of standard FDA clinical trial pathways. This represents Florida's attempt to implement "right-to-try" legislation, which has been adopted in various forms across multiple states and at the federal level.

Why is this important

The bill addresses a significant tension in medical regulation: patients facing terminal or severe conditions may want access to experimental treatments before they complete full FDA approval, potentially offering hope when standard options are exhausted. However, this directly conflicts with FDA oversight mechanisms designed to protect patients from ineffective or harmful treatments, creating a fundamental debate about individual choice versus public health safety standards.

Potential points of contention

  • Patient safety vs. autonomy: Unapproved treatments may be ineffective or cause serious harm, but restricting access denies desperately ill patients their preferred medical choices
  • FDA authority erosion: Right-to-try laws create parallel pathways outside established safety verification systems, potentially undermining regulatory standards
  • Equity concerns: Access to experimental treatments may depend on wealth and connections, creating disparities in who can pursue these options
  • Data collection gaps: Treatments accessed outside clinical trials generate no systematic safety or efficacy data, limiting medical knowledge gains

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.